Preventive strategies for hypercoagulation in Cushing’s syndrome: when and how

Thrombosis Journal

Table 1 Summary of studies reporting risk of venous thromboembolism and cardiovascular events in patients with Cushing’s syndrome

Author, year	Patients (n)	Risk of VTE	Risk of CV events
Huckhagel et al., 2023²	30	6.7%	-
Suarez et al., 2020³	208	9.8%	9%
Babic et al., 2019⁴	310	2.6%	-
Barbot et al., 2015⁵	78	3.8%	-
Koutroumpi et al., 2013⁶	58	14%	-
Van der Pas et al., 2012⁷	17	17.6%	-
Stuijver et al., 2011⁸	473	7.8%	-
Manetti et al., 2010⁹	40	7.5%	-
Kastelan et al., 2009¹⁰	33	9.1%	-
Sudhakar et al., 2004¹¹	22	4.5%	-
Rees et al., 2002¹²	54	5.6%	-
Boscaro et al., 2002¹³	307	9.4%	-
Semple et al., 1999¹⁴	105	3.8%	-
Fahlbusch et al., 1986¹⁵	101	7.9%	-
Small et al., 1983¹⁶	53	11%	7.5%
Zanon et al., 1982¹⁷	15	13.3%	-
Total	1904	8.4%*	8.3%*

CD – Cushing’s disease, CS – Cushing syndrome, CV – cardiovascular, VTE – venous thromboembolism events
* mean

ISSN: 1477-9560